Free Trial

Delta 9 Cannabis Q4 2023 Earnings Report

Delta 9 Cannabis EPS Results

Actual EPS
-C$0.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Delta 9 Cannabis Revenue Results

Actual Revenue
$17.48 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Delta 9 Cannabis Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

Delta 9 Cannabis Earnings Headlines

The Crypto Secret Wall Street Doesn’t Want You to Know
Potential $20-trillion opportunity? Put $500 into THIS AI Coin for 2025…
See More Delta 9 Cannabis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Delta 9 Cannabis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Delta 9 Cannabis and other key companies, straight to your email.

About Delta 9 Cannabis

Delta 9 Cannabis (TSE:DN), together with its subsidiaries, operates as an integrated cannabis company. The company engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products. Its products include dried cannabis flowers, pre-rolls, and dried sift cannabis, as well as oils, and extracted and derivative products. The company also offers grow pods and live plants to other licensed and pre-licensed companies. In addition, it operates as a medical clinic that provides physician consultation services to patients seeking a medical recommendation for a cannabis prescription. The company operates retail stores under the Delta 9 brand name across the Canadian provinces. It also exports its products to Australia. The company was incorporated in 2001 and is based in Vancouver, Canada.

View Delta 9 Cannabis Profile

More Earnings Resources from MarketBeat